AmWiner product formulas were combined with other active ingredients that treat other causes of hair loss, present in 70% of women, such as inflammatory scalp and Treatment for Cicatricial alopecia, follicular degeneration syndrome, and clogged pores. The goal is to keep patients healthier and off medication in the shortest possible time, by birthing a pathway of broad-spectrum hair loss treatment that would cover all likely causes of hair loss.

AmWiner is committed to improving the lives of people around the world by developing medicines that prevent, treat, and cure devastating skin diseases. We currently offer more than 25 therapies in the United States and are rapidly growing our portfolio through internal research and development, as well as collaborations with academic and industry partners.